Revelation Biosciences News, Revelation Biosciences Quote, REVB Quote

Revelation Biosciences (NQ:REVB) Delayed: 2.14 +0.05 (2.39%)

Prev. Close

$2.09

Open

$2.09

52 Wk High

$16.00

52 Wk Low

$10.65

Day High

$2.16

Day Low

$2.03

P/E

N/A

EPS

$0.00

Volume

8,443

Friends, Peers and Foes (?): REVBU (more...)

Apr 16, 2024 06:02 AM Form DEF 14A REVELATION BIOSCIENCES, For: Apr 15
Apr 5, 2024 04:03 PM Form PRE 14A REVELATION BIOSCIENCES, For: Apr 05
Mar 22, 2024 04:23 PM Form 8-K REVELATION BIOSCIENCES, For: Mar 22
Mar 22, 2024 04:15 PM Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023
Mar 22, 2024 04:02 PM Form 10-K REVELATION BIOSCIENCES, For: Dec 31
Mar 13, 2024 09:00 AM Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)
Mar 12, 2024 09:00 AM Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference
Mar 12, 2024 06:03 AM Form 8-K REVELATION BIOSCIENCES, For: Mar 12
Mar 4, 2024 12:14 PM Revere Bank (REVB) PT Raised to $25 at Roth/MKM
Mar 4, 2024 09:03 AM Revelation Biosciences (REVB) Commences First in Human Phase 1 Clinical Study of Gemini

Entities mentioned with revb